TMS.3.0.2007

More documents

Recommendations

Info

Transfusionsmedicinske Standarder. Version 3.0 21.9 har adgang til et større analyserepertoire, kan tilrettelægge deres initiale HBV algoritme i overensstemmelse hermed. © 1994-2007 Dansk Selskab for Klinisk Immunologi
21.10 Transfusionsmedicinske Standarder. Version 3.0 pos/pos pos/neg neg/pos Figur 21.1 Algoritme ved undersøgelse for anti-HIV-1/2 pos/pos/neg pos/neg/pos Donor indkaldes og informeres. Der tilbydes ny prøve og henvisning til klinisk ambulatorium. Tilbagekaldelsesprocedure og look-back iværksættes Ophører IB pos og/eller [DNA eller RNA NAT] pos Donorprøve EIA pos Gentag EIA x 2 pos/pos neg/pos Kassér blod IB og [p24Ag(EIA) eller RNA NAT] neg/neg Ink/neg Informér ikke donor Markér EIA/IB/[DNA eller RNA NAT] ved næste fremmøde 1. opfølgning EIA/IB/NAT alle andre udfald Informér ikke Markér EIA, IB og [DNA eller RNA NAT] ved næste fremmøde 2. opfølgning EIA/IB/[DNA eller RNA NAT] Alle andre udfald Skriftlig information om tekniske problemer Pause neg/neg © 1994-2007 Dansk Selskab for Klinisk Immunologi neg Blodet anvendes Kassér blod neg/neg/neg neg/ink/neg Kassér blod Normale procedurer fremover neg/neg/neg neg/ink/neg
Page 1 and 2:
Transfusionsmedicinske Standarder V
Page 3 and 4:
Transfusionsmedicinske Standarder.
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92: Transfusionsmedicinske Standarder.
Page 109 and 110: © 1994-2007 Dansk Selskab for Klin
Page 111 and 112: 17.2 Transfusionsmedicinske Standar
Page 131 and 132: 19.10 Transfusionsmedicinske Standa
Page 141: 21.8 Transfusionsmedicinske Standar
Page 161 and 162: A1.2 Transfusionsmedicinske Standar
Page 193 and 194:
Page 195 and 196:
A9.2 Transfusionsmedicinske Standar
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
A10.2 Transfusionsmedicinske Standa
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
A10.10 Transfusionsmedicinske Stand
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
show all

TMS.3.0.2007

Create successful ePaper yourself

Delete template?

Save as template?